H. Atmaca Et Al. , "Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling," CHEMICO-BIOLOGICAL INTERACTIONS , vol.263, pp.28-35, 2017
Atmaca, H. Et Al. 2017. Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling. CHEMICO-BIOLOGICAL INTERACTIONS , vol.263 , 28-35.
Atmaca, H., Ozkan, A. N., & ZORA, M., (2017). Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling. CHEMICO-BIOLOGICAL INTERACTIONS , vol.263, 28-35.
Atmaca, Harika, Ayse Nur Ozkan, And METİN ZORA. "Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling," CHEMICO-BIOLOGICAL INTERACTIONS , vol.263, 28-35, 2017
Atmaca, Harika Et Al. "Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling." CHEMICO-BIOLOGICAL INTERACTIONS , vol.263, pp.28-35, 2017
Atmaca, H. Ozkan, A. N. And ZORA, M. (2017) . "Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling." CHEMICO-BIOLOGICAL INTERACTIONS , vol.263, pp.28-35.
@article{article, author={Harika Atmaca Et Al. }, title={Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling}, journal={CHEMICO-BIOLOGICAL INTERACTIONS}, year=2017, pages={28-35} }